Cargando…
Elevated Cardiac Markers in Chronic Kidney Disease as a Consequence of Hyperphosphatemia-Induced Cardiac Myocyte Injury
BACKGROUND: Elevated cardiac markers (CMs) and hyperphosphatemia are commonly encountered in patients with chronic kidney diseases (CKD), but the causal relationship between them has not been established. MATERIAL/METHODS: We enrolled 151 patients with different kidney functions in a cross-sectional...
Autores principales: | Wang, Shu, Qin, Ling, Wu, Tianfu, Deng, Bingqing, Sun, Yuerun, Hu, Dayong, Mohan, Chandra, Zhou, Xin J., Peng, Ai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214699/ https://www.ncbi.nlm.nih.gov/pubmed/25344353 http://dx.doi.org/10.12659/MSM.890909 |
Ejemplares similares
-
Athletic Cardiac Adaptation in Males Is a Consequence of Elevated Myocyte Mass
por: McDiarmid, Adam K., et al.
Publicado: (2016) -
Phosphate intake, hyperphosphatemia, and kidney function
por: Rubio-Aliaga, Isabel, et al.
Publicado: (2022) -
Redox signaling in cardiac myocytes
por: Santos, Celio X.C., et al.
Publicado: (2011) -
Hyperphosphatemia: The hidden killer in chronic kidney disease
por: Askar, Akram M.
Publicado: (2015) -
Hyperphosphatemia Management in Patients with Chronic Kidney Disease
por: Shaman, Ahmed M., et al.
Publicado: (2016)